Testosterone replacement therapy has gained significant attention as the U.S. military plans to test and potentially treat service members with low testosterone levels.
This initiative, announced by Defense Secretary Pete Hegseth, aligns with a broader movement to increase access to testosterone therapies, which have seen a rise in prescriptions from 7.3 million in 2019 to over 11 million in 2024, according to IQVIA.
While testosterone therapy can benefit men with clinically confirmed deficiencies, concerns persist regarding its safety and efficacy for those without a clear medical need.
Experts emphasize that testosterone therapy is not a universal solution and should be reserved for men diagnosed with hypogonadism, as excess testosterone can lead to health risks, including reduced fertility and increased blood clotting.
The military's approach raises questions about how to interpret testosterone levels in individuals under extreme stress, as factors like intense training and sleep deprivation can temporarily lower hormone levels. Overall, while the therapy may enhance performance for some, its broader application requires careful consideration and monitoring